Vitamin D Levels and Breast Cancer Prognosis
Author Information
Author(s): Yao Song, Sucheston Lara E., Millen Amy E., Johnson Candace S., Trump Donald L., Nesline Mary K., Davis Warren, Hong Chi-Chen, McCann Susan E., Hwang Helena, Kulkarni Swati, Edge Stephen B., O'Connor Tracey L., Ambrosone Christine B.
Primary Institution: Roswell Park Cancer Institute
Hypothesis
Higher serum concentrations of 25-hydroxyvitamin D may reduce the risk of breast cancer, particularly for aggressive subtypes.
Conclusion
Higher serum levels of 25OHD are associated with reduced risk of breast cancer, especially for high grade, ER negative, or triple negative cancers in premenopausal women.
Supporting Evidence
- Breast cancer cases had significantly lower 25OHD concentrations than controls.
- Premenopausal women with higher 25OHD levels had lower odds of triple-negative cancer.
- Every 10 ng/mL increase in serum 25OHD was associated with a 64% lower odds of having triple-negative cancer.
- Vitamin D deficiency was more prevalent among breast cancer cases compared to controls.
Takeaway
This study found that women with higher vitamin D levels are less likely to have aggressive types of breast cancer.
Methodology
Case-control and case-series analyses examining serum 25OHD concentrations in relation to breast cancer prognostic characteristics among women with breast cancer and matched controls.
Potential Biases
Potential bias due to self-reported data on lifestyle factors and demographics.
Limitations
Only a single measurement of vitamin D at diagnosis was used, which may not represent levels at cancer initiation.
Participant Demographics
579 women with incident breast cancer and 574 matched controls, primarily non-Hispanic white.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 0.08–0.53
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website